This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Schizophrenia
  • /
  • A 6-year open-label study of the efficacy and safe...

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation.

Read time: 1 mins
Published:25th Mar 2020
Author: Anand E, Berggren L, Deix C, Tóth Á, McDonnell DP.
Ref.:Neuropsychiatr Dis Treat. 2015 May 27;11:1349-57.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest